TherageniX

About:

TherageniX delivers genes that direct the body to make necessary proteins or substances that aid in tissue regeneration.

Website: https://theragenix.health

Top Investors: Innovate UK

Description:

TherageniX delivers genes that direct the body to make necessary proteins or substances that aid in tissue regeneration using patented technology. TherageniX's technology employs a proprietary non-viral delivery system to distribute targeted regeneration factor genes (e.g., VEGF and BMP for vascularization and osteogenesis, respectively) as well as autologous bone marrow cells from the patient.

Total Funding Amount:

995000 GBP

Headquarters Location:

London, England, United Kingdom

Founded Date:

2022-01-01

Contact Email:

info(AT)theragenix.health

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-08-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai